We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEB icon
2601
Seaboard Corp
SEB
$4.08B
$107K ﹤0.01%
30
+24
+400% +$85.4K
PBUS icon
2602
Invesco MSCI USA ETF
PBUS
$11.9B
$107K ﹤0.01%
+2,240
New +$99.8K
RCKT icon
2603
Rocket Pharmaceuticals
RCKT
$367M
$107K ﹤0.01%
3,557
+1,829
+106% +$40.4K
EVV
2604
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$107K ﹤0.01%
11,127
+11,122
+222,440% +$101K
ICVX
2605
DELISTED
Icosavax, Inc. Common Stock
ICVX
$106K ﹤0.01%
6,728
+4,546
+208% +$43.8K
THFF icon
2606
First Financial Corp
THFF
$975M
$106K ﹤0.01%
2,464
-10,584
-81% -$395K
EGLE
2607
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$106K ﹤0.01%
1,913
-15,366
-89% -$694K
TWST icon
2608
Twist Bioscience
TWST
$7.86B
$106K ﹤0.01%
2,874
-3,103
-52% -$71.8K
HTGC icon
2609
Hercules Capital
HTGC
$3.17B
$106K ﹤0.01%
6,345
+3,039
+92% +$48.1K
TPB icon
2610
Turning Point Brands
TPB
$1.73B
$106K ﹤0.01%
4,017
+3,419
+572% +$78.2K
KRTX
2611
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$106K ﹤0.01%
334
-1,176
-78% -$229K
PLCE icon
2612
Children's Place
PLCE
$53.4M
$106K ﹤0.01%
4,550
+4,335
+2,016% +$105K
SPHQ icon
2613
Invesco S&P 500 Quality ETF
SPHQ
$20.1B
$106K ﹤0.01%
1,952
+1,865
+2,144% +$95.9K
CFB
2614
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$105K ﹤0.01%
7,765
+6,792
+698% +$77.8K
DX
2615
Dynex Capital
DX
$3.23B
$105K ﹤0.01%
8,378
+1,044
+14% +$11.9K
ALPN
2616
DELISTED
Alpine Immune Sciences Inc
ALPN
$105K ﹤0.01%
5,490
+4,417
+412% +$61.4K
CIG icon
2617
CEMIG Preferred Shares
CIG
$5.58B
$105K ﹤0.01%
58,577
-3,438
-6% -$6.23K
ARES icon
2618
Ares Management
ARES
$33.7B
$104K ﹤0.01%
877
-9,712
-92% -$1.05M
CGEM icon
2619
Cullinan Oncology
CGEM
$1.26B
$104K ﹤0.01%
10,234
-5,156
-34% -$45.7K
EOLS icon
2620
Evolus
EOLS
$530M
$104K ﹤0.01%
9,876
-1,732
-15% -$15.5K
CPRX
2621
DELISTED
Catalyst Pharmaceutical
CPRX
$104K ﹤0.01%
6,184
+2,833
+85% +$38.7K
NCNO icon
2622
nCino
NCNO
$2.26B
$104K ﹤0.01%
3,080
-1,977
-39% -$58.8K
UIS icon
2623
Unisys
UIS
$210M
$103K ﹤0.01%
18,415
+16,871
+1,093% +$71.6K
SPB icon
2624
Spectrum Brands
SPB
$2.09B
$103K ﹤0.01%
1,295
-667
-34% -$50.3K
ALNT icon
2625
Allient
ALNT
$1.86B
$103K ﹤0.01%
3,411
+2,128
+166% +$60K
103 104
105
106 107

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.